IONS logo

Ionis Pharmaceuticals (IONS) Cash and cash equivalents

annual cash & cash equivalents:

$242.08M-$157.19M(-39.37%)
December 31, 2024

Summary

  • As of today (May 29, 2025), IONS annual cash & cash equivalents is $242.08 million, with the most recent change of -$157.19 million (-39.37%) on December 31, 2024.
  • During the last 3 years, IONS annual cash & cash equivalents has fallen by -$627.11 million (-72.15%).
  • IONS annual cash & cash equivalents is now -72.15% below its all-time high of $869.19 million, reached on December 31, 2021.

Performance

IONS Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSbalance sheet metrics

quarterly cash & cash equivalents:

$264.19M+$22.11M(+9.14%)
March 31, 2025

Summary

  • As of today (May 29, 2025), IONS quarterly cash & cash equivalents is $264.19 million, with the most recent change of +$22.11 million (+9.14%) on March 31, 2025.
  • Over the past year, IONS quarterly cash & cash equivalents has dropped by -$84.70 million (-24.28%).
  • IONS quarterly cash & cash equivalents is now -69.60% below its all-time high of $869.19 million, reached on December 31, 2021.

Performance

IONS quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

IONS Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-39.4%-24.3%
3 y3 years-72.2%-51.3%
5 y5 years-64.6%-45.7%

IONS Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-72.2%at low-51.3%+9.1%
5 y5-year-72.2%at low-69.6%+9.1%
alltimeall time-72.2%>+9999.0%-69.6%>+9999.0%

IONS Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$264.19M(+9.1%)
Dec 2024
$242.08M(-39.4%)
$242.08M(-27.7%)
Sep 2024
-
$334.61M(+13.8%)
Jun 2024
-
$293.99M(-15.7%)
Mar 2024
-
$348.89M(-12.6%)
Dec 2023
$399.27M(+44.4%)
$399.27M(+13.4%)
Sep 2023
-
$352.06M(-17.1%)
Jun 2023
-
$424.79M(+37.5%)
Mar 2023
-
$309.03M(+11.8%)
Dec 2022
$276.47M(-68.2%)
$276.47M(-12.2%)
Sep 2022
-
$314.99M(-39.6%)
Jun 2022
-
$521.92M(-3.8%)
Mar 2022
-
$542.51M(-37.6%)
Dec 2021
$869.19M(+118.6%)
$869.19M(+37.3%)
Sep 2021
-
$632.95M(+12.0%)
Jun 2021
-
$565.12M(+36.5%)
Mar 2021
-
$414.15M(+4.1%)
Dec 2020
$397.66M(-41.8%)
$397.66M(-37.2%)
Sep 2020
-
$633.06M(+19.4%)
Jun 2020
-
$530.18M(+9.0%)
Mar 2020
-
$486.19M(-28.8%)
Dec 2019
$683.29M(+145.1%)
$683.29M(+175.6%)
Sep 2019
-
$247.94M(-9.0%)
Jun 2019
-
$272.52M(-27.5%)
Mar 2019
-
$375.81M(+34.8%)
Dec 2018
$278.82M(+115.1%)
$278.82M(-41.9%)
Sep 2018
-
$479.89M(-40.4%)
Jun 2018
-
$805.49M(+254.1%)
Mar 2018
-
$227.50M(+75.5%)
Dec 2017
$129.63M(+53.1%)
$129.63M(-18.6%)
Sep 2017
-
$159.18M(+19.7%)
Jun 2017
-
$132.99M(+16.4%)
Mar 2017
-
$114.22M(+34.9%)
Dec 2016
$84.69M(-34.2%)
$84.69M(+0.5%)
Sep 2016
-
$84.28M(-25.1%)
Jun 2016
-
$112.53M(+20.6%)
Mar 2016
-
$93.34M(-27.5%)
Dec 2015
$128.80M(-9.9%)
$128.80M(+1.7%)
Sep 2015
-
$126.59M(+5.9%)
Jun 2015
-
$119.49M(-19.5%)
Mar 2015
-
$148.35M(+3.7%)
Dec 2014
$143.00M(-10.6%)
$143.00M(+95.3%)
Sep 2014
-
$73.22M(-22.2%)
Jun 2014
-
$94.08M(-41.8%)
Mar 2014
-
$161.78M(+1.1%)
Dec 2013
$159.97M(+28.5%)
$159.97M(-37.6%)
Sep 2013
-
$256.41M(-13.5%)
Jun 2013
-
$296.54M(+175.5%)
Mar 2013
-
$107.65M(-13.5%)
Dec 2012
$124.48M(+90.1%)
$124.48M(+47.2%)
Sep 2012
-
$84.56M(-1.3%)
Jun 2012
-
$85.64M(+51.9%)
Mar 2012
-
$56.39M(-13.9%)
Dec 2011
$65.48M(-6.5%)
$65.48M(+18.5%)
Sep 2011
-
$55.26M(-35.0%)
Jun 2011
-
$85.02M(-1.4%)
Mar 2011
-
$86.20M(+23.1%)
Dec 2010
$70.05M(-33.4%)
$70.05M(-30.0%)
Sep 2010
-
$100.12M(+117.5%)
Jun 2010
-
$46.04M(-53.3%)
Mar 2010
-
$98.59M(-6.3%)
Dec 2009
$105.25M(-51.7%)
$105.25M(-29.5%)
Sep 2009
-
$149.29M(-30.8%)
Jun 2009
-
$215.79M(-15.1%)
Mar 2009
-
$254.06M(+16.6%)
Dec 2008
$217.92M(+57.2%)
$217.92M(-17.7%)
Sep 2008
-
$264.68M(-40.6%)
Jun 2008
-
$445.72M(+63.9%)
Mar 2008
-
$271.94M(+96.2%)
DateAnnualQuarterly
Dec 2007
$138.61M(+21.0%)
$138.61M(+35.4%)
Sep 2007
-
$102.40M(-23.0%)
Jun 2007
-
$132.96M(-27.5%)
Mar 2007
-
$183.42M(+60.2%)
Dec 2006
$114.51M(+3037.4%)
$114.51M(+9.9%)
Sep 2006
-
$104.24M(-1.1%)
Jun 2006
-
$105.36M(+6057.7%)
Mar 2006
-
$1.71M(-53.1%)
Dec 2005
$3.65M(-86.6%)
$3.65M(-93.1%)
Sep 2005
-
$53.22M(+566.3%)
Jun 2005
-
$7.99M(-33.5%)
Mar 2005
-
$12.01M(-55.9%)
Dec 2004
$27.25M(-17.7%)
$27.25M(+27.1%)
Sep 2004
-
$21.45M(-29.4%)
Jun 2004
-
$30.37M(-23.6%)
Mar 2004
-
$39.76M(+20.1%)
Dec 2003
$33.12M(-67.5%)
$33.12M(-40.6%)
Sep 2003
-
$55.79M(-34.6%)
Jun 2003
-
$85.32M(+39.7%)
Mar 2003
-
$61.09M(-40.0%)
Dec 2002
$101.86M(-19.8%)
$101.86M(+9.4%)
Sep 2002
-
$93.08M(-15.4%)
Jun 2002
-
$110.02M(+19.0%)
Mar 2002
-
$92.45M(-27.2%)
Dec 2001
$127.01M(+220.6%)
$127.01M(+931.7%)
Sep 2001
-
$12.31M(-3.3%)
Jun 2001
-
$12.74M(+58.1%)
Mar 2001
-
$8.06M(-79.7%)
Dec 2000
$39.62M(+12.2%)
$39.62M(-32.9%)
Sep 2000
-
$59.03M(-4.9%)
Jun 2000
-
$62.04M(-4.2%)
Mar 2000
-
$64.73M(+83.4%)
Dec 1999
$35.30M(+27.9%)
$35.30M(-7.8%)
Sep 1999
-
$38.30M(+11.3%)
Jun 1999
-
$34.40M(+69.5%)
Mar 1999
-
$20.30M(-26.4%)
Dec 1998
$27.60M(-27.6%)
$27.60M(-27.4%)
Sep 1998
-
$38.00M(-2.3%)
Jun 1998
-
$38.90M(+39.9%)
Mar 1998
-
$27.80M(-27.0%)
Dec 1997
$38.10M(+2.7%)
$38.10M(+31.8%)
Sep 1997
-
$28.90M(-19.5%)
Jun 1997
-
$35.90M(+37.0%)
Mar 1997
-
$26.20M(-29.4%)
Dec 1996
$37.10M(-20.2%)
$37.10M(+43.8%)
Sep 1996
-
$25.80M(+1.2%)
Jun 1996
-
$25.50M(+12.8%)
Mar 1996
-
$22.60M(-51.4%)
Dec 1995
$46.50M(+260.5%)
$46.50M(+87.5%)
Sep 1995
-
$24.80M(+31.9%)
Jun 1995
-
$18.80M(+13.3%)
Mar 1995
-
$16.60M(+28.7%)
Dec 1994
$12.90M(-61.7%)
$12.90M(-20.4%)
Sep 1994
-
$16.20M(-12.0%)
Jun 1994
-
$18.40M(-44.6%)
Mar 1994
-
$33.20M(-1.5%)
Dec 1993
$33.70M(+104.2%)
$33.70M(+88.3%)
Sep 1993
-
$17.90M(-17.5%)
Jun 1993
-
$21.70M(-19.6%)
Mar 1993
-
$27.00M(+63.6%)
Dec 1992
$16.50M(-22.2%)
$16.50M(+13.0%)
Sep 1992
-
$14.60M(+10.6%)
Jun 1992
-
$13.20M(-17.5%)
Mar 1992
-
$16.00M(-24.5%)
Dec 1991
$21.20M(+1077.8%)
$21.20M(+17.1%)
Sep 1991
-
$18.10M(-46.1%)
Jun 1991
-
$33.60M(+115.4%)
Mar 1991
-
$15.60M(+766.7%)
Dec 1990
$1.80M
$1.80M

FAQ

  • What is Ionis Pharmaceuticals annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals annual cash & cash equivalents year-on-year change?
  • What is Ionis Pharmaceuticals quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals quarterly cash & cash equivalents year-on-year change?

What is Ionis Pharmaceuticals annual cash & cash equivalents?

The current annual cash & cash equivalents of IONS is $242.08M

What is the all time high annual cash & cash equivalents for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high annual cash & cash equivalents is $869.19M

What is Ionis Pharmaceuticals annual cash & cash equivalents year-on-year change?

Over the past year, IONS annual cash & cash equivalents has changed by -$157.19M (-39.37%)

What is Ionis Pharmaceuticals quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of IONS is $264.19M

What is the all time high quarterly cash & cash equivalents for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high quarterly cash & cash equivalents is $869.19M

What is Ionis Pharmaceuticals quarterly cash & cash equivalents year-on-year change?

Over the past year, IONS quarterly cash & cash equivalents has changed by -$84.70M (-24.28%)
On this page